Menthol
- Generic Name
- Menthol
- Brand Names
- Activon Arthritis, Bengay, Calazime Skin Protectant, Calmodrox, Calmoseptine Ointment, Capzasin Quick Relief, Chloraseptic Sore Throat, Chloraseptic Sore Throat + Cough, Delsym Cough Plus Soothing Action, Delsym Cough Relief Plus Soothing Action, Dendracin Neurodendraxcin, Fast Freeze, Flexall Ultra Plus, Gold Bond Maximum Relief, Icy Hot Arthritis, Ivy-dry Cream, Lidopro, Lidothol, Listerine Antiseptic, Max-freeze, Medi-derm, Medi-derm With Lidocaine, Medicaine Sting and Bite, Medrox, Men-phor, Mentholatum, Orasep Reformulated Dec 2013, Ortho-nesic, Rematex, Salonpas Gel-patch, Salonpas Pain Relieving Patch, Sarna Sensitive, Sucrets, Tiger Balm, Vaporex, Vicks Vaporub, Xoten-C
- Drug Type
- Small Molecule
- Chemical Formula
- C10H20O
- CAS Number
- 1490-04-6
- Unique Ingredient Identifier
- L7T10EIP3A
Pharmacokinetics Study Comparing Topical Diclofenac/Menthol Gels With Voltaren Gel and Oral Diclofenac Sodium
- First Posted Date
- 2014-07-28
- Last Posted Date
- 2017-06-29
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 18
- Registration Number
- NCT02201238
- Locations
- πΊπΈ
GSK Investigational Site, Buffalo, New York, United States
A Safety Study to Investigate the Skin Sensitization Potential of MFC51123
Phase 1
Completed
- Conditions
- Pain
- Interventions
- First Posted Date
- 2014-07-16
- Last Posted Date
- 2017-06-28
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 227
- Registration Number
- NCT02192203
- Locations
- πΊπΈ
TKL Research Inc, Paramus, New Jersey, United States
A Safety Study to Investigate the Skin Irritancy Potential of Diclofenac-Menthol Gel
Phase 1
Completed
- Conditions
- Pain
- Interventions
- Drug: 0.2% Sodium Lauryl SulfateDrug: 0.9% SalineDrug: 1% Diclofenac Sodium
- First Posted Date
- 2014-06-23
- Last Posted Date
- 2017-06-29
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 36
- Registration Number
- NCT02169154
- Locations
- πΊπΈ
TKL Research Inc, Paramus, New Jersey, United States
The Effects of Menthol as Delivered by an Electronic Cigarette on the Desirability of Nicotine in Tobacco Users
- First Posted Date
- 2014-04-02
- Last Posted Date
- 2020-03-19
- Lead Sponsor
- Yale University
- Target Recruit Count
- 57
- Registration Number
- NCT02102100
- Locations
- πΊπΈ
Connecticut VA Healthcare System, West Haven, Connecticut, United States
πΊπΈVA Connecticut Health Care System, West Haven, Connecticut, United States
A Multicenter Efficacy Study of a Diclofenac+Menthol Gel in Subjects With Ankle Sprain
Phase 3
Completed
- Conditions
- Pain
- Interventions
- Drug: Placebo with 0.09% menthol gel
- First Posted Date
- 2014-04-01
- Last Posted Date
- 2018-01-12
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 385
- Registration Number
- NCT02100670
- Locations
- π©πͺ
PAREXEL International - Sites in Germany, Berlin, Germany
π©πͺPAREXEL International, LLC, Berlin, Germany
π©πͺpro scientia med im MARE Klinikum, Kiel, Germany
Topical Menthol for the Treatment of Chemotherapy Induced Peripheral Neuropathy
Phase 2
Terminated
- Conditions
- NeuropathyBreast CancerColon Cancer
- Interventions
- Drug: placebo lotion
- First Posted Date
- 2013-05-16
- Last Posted Date
- 2024-07-11
- Lead Sponsor
- Columbia University
- Target Recruit Count
- 12
- Registration Number
- NCT01855607
- Locations
- πΊπΈ
Herbert Irving Comprehensive Cancer Center, New York, New York, United States
Phase III Open-labeled Study of NPO-11 in Patients Undergoing Therapeutic Upper Gastrointestinal Endoscopy
Phase 3
Completed
- Conditions
- Gastric CancerColon Nos Polypectomy Tubular AdenomaGastric Adenoma
- Interventions
- First Posted Date
- 2011-08-08
- Last Posted Date
- 2012-06-29
- Lead Sponsor
- Nihon Pharmaceutical Co., Ltd
- Target Recruit Count
- 33
- Registration Number
- NCT01411189
- Locations
- π―π΅
Nihon Pharmaceutical Co., Ltd, Tokyo, Japan
Phase III Study of NPO-11 in Patients Undergoing Therapeutic Upper Gastrointestinal Endoscopy
- First Posted Date
- 2011-08-08
- Last Posted Date
- 2012-06-29
- Lead Sponsor
- Nihon Pharmaceutical Co., Ltd
- Target Recruit Count
- 85
- Registration Number
- NCT01411176
- Locations
- π―π΅
Nihon Pharmaceutical Co., Ltd, Tokyo, Japan
Effects and Safety of Menthol on Blood Pressure and Metabolic Parameters in Prehypertensive and Mild Hypertensive Patients
- First Posted Date
- 2011-08-03
- Last Posted Date
- 2020-03-11
- Lead Sponsor
- Zhiming Zhu
- Target Recruit Count
- 36
- Registration Number
- NCT01408446
- Locations
- π¨π³
The Third Military Medical University, Chongqing, Chongqing, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
Β© Copyright 2025. All Rights Reserved by MedPath